Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2026-01-31 @ 3:03 AM
Study NCT ID:
NCT04739150
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-09-09
First Post:
2021-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Diseases, Interstitial | View |
Keywords: